info@axxam.com
  • LinkedIn
  • LinkedIn
  • AXXAM
AXXSense
  • Company
    • About us
    • History
    • Business Model
    • Partnerships
    • Corporate Social Responsability
  • Biological Platforms
    • Olfactory
    • Sweet
    • Bitter
    • Trigeminal
    • Salt
    • Fatty Acid
    • Kokumi
    • Umami
  • Technology Platforms
    • Assay Development
    • Compound Profiling
    • High Throughput Screening
    • High Content Imaging
  • Compound Collections
    • NatPure
    • PreFrac
    • Advance Extract
    • Microbial Strain
    • Bioprofiling
    • Synthetic Compound Library
      • AXXDiversity
  • Application fields
    • Food
    • Beverage
    • Fragrance
    • Cosmetics
    • Animal Food
    • Animal Health
    • Malodour
    • Enhancers
  • Webinar&Content
  • Contact us
Select Page

Keensight Capital to acquire a majority stake in Axxam, a leading European partner research organization in life sciences

Jul 28, 2022 | Press Release

Read the press release in PDF >

IMAX Discovery logo b, bioactive molecules, flavors, fragrances, taste, food, beverage, pet food, cosmetic, perfume
Business address:
Openzone Campus
Via Meucci, 3 – 20091 Bresso
Milan, Italy
info@axxam.com
IMAX Discovery, Axxam, Byk-Gulden-Strasse-2, 78467 Konstanz, Germany
IMAX Discovery, AXXAM, innovates, enables, performs
COMPANY
About us
History
Business Model

BIOLOGICAL PLATFORMS
Olfactory
Sweet
Bitter
Trigeminal
Salt
Fatty Acid
Kokumi
Umami

TECHNOLOGY PLATFORMS
Assay Development
Compound Profiling
High Throughput Screening
High Content Imaging

COMPOUND COLLECTIONS
NatPure Library
PreFrac Library
Advanced Extracts Library
Microbial Strain Library
Bioprofiling
Synthetic Compound Collection

APPLICATION FIELDS
Food
Beverage
Fragrance
Cosmetics
Animal Food
Animal Health
Malodour
Enhancers

WEBINARS & PUBLICATIONS

CONTACT US

Newsletter AXXSense

Find AXXSense on AXXAM profile on Scientist.com >

Copyright © 2025 Axxam S.p.A. All rights reserved | Privacy & Cookie Policy
  • Follow